Report recommends insurers use prescription monitoring data to reduce opioid abuse, deaths

April 22, 2014

WALTHAM, Mass. - The Prescription Drug Monitoring Program Center of Excellence at Brandeis University has issued a ground-breaking report recommending that medical insurers use prescription monitoring data to reduce the overdoses, deaths and health care costs associated with abuse of opioids and other prescription drugs.

"At a time when the misuse and abuse of prescription opioids has reached epidemic levels, it's important that third party payers be able to use states' prescription monitoring data to make sure these drugs are prescribed appropriately," said Peter Kreiner, principal investigator of the Prescription Drug Monitoring Program (PDMP) Center of Excellence.

The report, available online, describes the proceedings of a December 2012 meeting of more than 75 medical insurers, federal agency heads and state PDMP administrators, who explored the value and feasibility of PDMPs sharing its prescription data with third party payers.

"This report documents the emerging consensus among leaders in the insurance and workers' compensation industry that knowing the full prescription history of an insured patient will help to provide safe and effective care and keep costs under control," said John Eadie, PDMP Center of Excellence director.

The meeting was convened by the Center of Excellence as called for by the Office of National Drug Control Policy in its 2011 Prescription Drug Abuse Prevention Plan. It was funded by a grant from the U.S. Department of Justice, Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program, which develops and encourages the adoption of PDMP best practices.

"With the support and expertise of the PDMP Center of Excellence and the PDMP Training and Technical Assistance Center at Brandeis University, almost every state in the country has a prescription drug monitoring program," said Congressman Hal Rogers of Kentucky. "These important tools serve the dual function of promoting good medicine and effective law enforcement, and as co-chairman of the Congressional Caucus on Prescription Drug Abuse, I am heartened by efforts to expand access to PDMPs so that we can prevent the abuse and misuse of powerful medications."

As detailed in the report, meeting participants agreed that data sharing between PDMPs and third party payers would significantly enhance insurers' capability to monitor prescribing of opioids and other commonly abused prescription drugs, permitting better detection of inappropriate prescribing and dispensing. Workgroups at the meeting formulated data sharing policies and procedures for consideration by regulatory agencies.

Most third party payers, including Medicare, Medicaid and workers' compensation programs, only see data on prescriptions for which their respective plans have paid. But PDMP data provide an individual's complete outpatient prescription history for controlled substances, including, for example, those for which a "doctor-shopping" patient or one acting in collusion with a street dealer had purchased for cash.

By enabling insurers to see their enrollees' activity beyond their respective health plans, PDMP data also would provide payers with efficient--and most importantly with respect to patient safety--early identification of unscrupulous or otherwise dangerous controlled substance prescribing and dispensing.

"Opioid abuse is the most urgent issue in workers' compensation," said Bruce Wood, director of Workers' Compensation with the American Insurance Association. "Giving workers' compensation payers access to PDMP information would permit them to see if an injured worker is getting opioids from multiple sources."

"Prescription drug diversion is a serious problem across the U.S. that puts lives in jeopardy and costs consumers and insurers billions of dollars each year," added Dennis Jay, executive director of the Coalition Against Insurance Fraud.

"Sharing prescription monitoring data will help public and private insurers better detect abuse and fraud involving prescription drugs, and ultimately save money and lives."

The report will be discussed at the National Rx Drug Abuse Summit in Atlanta, Tuesday, April 22, 1:45-3 p.m., during the panel presentation on "PDMP Coordination with Third-Party Administrators."
-end-
The PDMP Center of Excellence at Brandeis provides academically sound and practice-relevant information, evaluation, and expertise to PDMPs and their stakeholders. It is funded by grants from the U.S. Department of Justice, Bureau of Justice Assistance. For more information, please visit http://www.pdmpexcellence.org

Contact:

Tom Clark
PDMP Center of Excellence Clearinghouse Manager
twclark@brandeis.edu
(781) 736-3970

Brandeis University

Related Opioids Articles from Brightsurf:

One in 10 older dental patients inappropriately prescribed opioids
A new study by researchers at the University of Illinois Chicago and the University of Pittsburgh suggests that a significant proportion of older patients receiving opioids at dental visits also use psychotropic medications -- a potentially harmful combination.

Look beyond opioids to solve national substance use epidemic, study suggests
A new study published reveals that three-quarters of participants in an inpatient addiction intervention program at Oregon Health & Science University came into the hospital using more than one substance.

Placenta can indicate how body responds to opioids during pregnancy
Scientists at the University of Missouri have discovered possible biological markers that they hope could one day help identify the presence of an opioid use disorder during human pregnancy.

Research Finds Women Often Overprescribed Opioids After Childbirth
Excessive opioid prescriptions following childbirth may lead to higher rates of addiction within communities, according to a new report in The Journal of the American Osteopathic Association.

Women significantly more likely to be prescribed opioids, study shows
Women are significantly more likely to receive prescriptions of opioid analgesics.

Opioids for chronic non-cancer pain doubled in quarter century
A review of 24 years of global research has shown opioid prescribing doubled between 1991-2015, with demand most common for chronic conditions such as chronic lower back pain, finds University of Sydney-led research.

Cancer screening among women prescribed opioids
US women who take prescription opioids are no less likely to receive key cancer screenings when compared to women who are not prescribed opioids.

Parents: Turkey makes great leftovers -- opioids do not
Leftover prescription opioids pose big risks to kids, yet most parents keep their own and their child's unused painkillers even after they're no longer medically necessary for pain.

Co-addiction of meth and opioids hinders treatment
A study published in the Journal of Substance Abuse Treatment found that methamphetamine use was associated with more than twice the risk for dropping out of treatment for opioid-use disorder.

Computer game may help to predict reuse of opioids
A computer betting game can help predict the likelihood that someone recovering from opioid addiction will reuse the pain-relieving drugs, a new study shows.

Read More: Opioids News and Opioids Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.